Gwendal Le Masson

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Activity-Dependent Regulation of Conductances in Model Neurons

Gwendal Le Masson, Eve Marder, L. F. Abbott · Science · 1993 · 340 citations

Synaptic Transmission, Channel Turnover, Neurotransmission +17

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 258 citations · Full text

Subcutaneous Immunoglobulin, Autoimmune Disease, Chronic Inflammatory +12

Feedback inhibition controls spike transfer in hybrid thalamic circuits

Gwendal Le Masson, Sylvie Renaud, Damien Debay et al. · Nature · 2002 · 206 citations

Neurodynamics, Neurophysiology, Computational Neuroscience +7

Synaptic background activity controls spike transfer from thalamus to cortex

Jakob Wolfart, Damien Debay, Gwendal Le Masson et al. · Nature Neuroscience · 2005 · 200 citations

Synaptic Plasticity, Neural Mechanism, Neurodynamics +12